HCPCS code J1611 — Inj glucagon hcl, fresenius. Status: Active. Effective Jan 1, 2023. Source: CMS HCPCS Level II.

J1611

Active

Inj glucagon hcl, fresenius

Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Jan 1, 2023
Code type: alphanumeric
OPPS Status: K — Non-pass-through drugs and biologicals
OPPS APC: 9025

MUE — Medically Unlikely Edits

Maximum units of J1611 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
Outpatient Hospital 2
Practitioner Services 2

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
63323-0582-82 Glucagon Emergency
63323-0593-03 Glucagon
63323-0594-03 Glucagen
63323-0596-13 Glucagon
63323-0596-16 Glucagon

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2023-Q1
    Inj glucagon hcl, fresenius